Cargando…

Treatments in depression

Major depression is believed to be a multifactorial disorder involving predisposing temperament and personality traits, exposure to traumatic and stressful life events, and biological susceptibility. Depression, both unipolar and bipolar, is a “phasic” disease. Stressful life events are known to tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Duval, Fabrice, Lebowitz, Barry D., Macher, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181767/
https://www.ncbi.nlm.nih.gov/pubmed/16889105
_version_ 1782212807708639232
author Duval, Fabrice
Lebowitz, Barry D.
Macher, Jean-Paul
author_facet Duval, Fabrice
Lebowitz, Barry D.
Macher, Jean-Paul
author_sort Duval, Fabrice
collection PubMed
description Major depression is believed to be a multifactorial disorder involving predisposing temperament and personality traits, exposure to traumatic and stressful life events, and biological susceptibility. Depression, both unipolar and bipolar, is a “phasic” disease. Stressful life events are known to trigger depressive episodes, while their influence seems to decrease over the course of the illness. This suggests that depression is associated with progressive stress response abnormalities, possibly linked to impairments of structural plasticity and cellular resilience. It therefore appears crucial to adequately treat depression in the early stages of the illness, in order to prevent morphological and functional abnormalities. While evidence suggests that a severely depressed patient needs antidepressant drug therapy and that a non-severely depressed patient may benefit from other approaches (ie, “nonbiological”), little research has been done on the effectiveness of different treatments for depression. The assertion that the clinical efficacy of antidepressants is comparable between the classes and within the classes of those medications may be true from a statistical viewpoint, but is of limited value in practice. The antidepressant drugs may produce differences in therapeutic response and tolerability. Among the possible predictors of outcome in depression treatment, those derived from clinical assessment, neuroendocrine investigations, polysomnographic sleep parameters, genetic variables, and brain imaging techniques have been extensively studied. This article also reviews therapeutic strategies used when initial treatment fails, and describes briefly new concepts in antidepressant therapies such as the regulation of disturbances in circadian rhythms. The treatment of depressive illness does not stop with treatment of acute episodes, and has to be envisaged as a continuous therapeutic intervention, of which we are still not able to determine the optimal duration of treatment and the moment that it should be ceased.
format Online
Article
Text
id pubmed-3181767
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31817672011-10-27 Treatments in depression Duval, Fabrice Lebowitz, Barry D. Macher, Jean-Paul Dialogues Clin Neurosci Pharmacological Aspects Major depression is believed to be a multifactorial disorder involving predisposing temperament and personality traits, exposure to traumatic and stressful life events, and biological susceptibility. Depression, both unipolar and bipolar, is a “phasic” disease. Stressful life events are known to trigger depressive episodes, while their influence seems to decrease over the course of the illness. This suggests that depression is associated with progressive stress response abnormalities, possibly linked to impairments of structural plasticity and cellular resilience. It therefore appears crucial to adequately treat depression in the early stages of the illness, in order to prevent morphological and functional abnormalities. While evidence suggests that a severely depressed patient needs antidepressant drug therapy and that a non-severely depressed patient may benefit from other approaches (ie, “nonbiological”), little research has been done on the effectiveness of different treatments for depression. The assertion that the clinical efficacy of antidepressants is comparable between the classes and within the classes of those medications may be true from a statistical viewpoint, but is of limited value in practice. The antidepressant drugs may produce differences in therapeutic response and tolerability. Among the possible predictors of outcome in depression treatment, those derived from clinical assessment, neuroendocrine investigations, polysomnographic sleep parameters, genetic variables, and brain imaging techniques have been extensively studied. This article also reviews therapeutic strategies used when initial treatment fails, and describes briefly new concepts in antidepressant therapies such as the regulation of disturbances in circadian rhythms. The treatment of depressive illness does not stop with treatment of acute episodes, and has to be envisaged as a continuous therapeutic intervention, of which we are still not able to determine the optimal duration of treatment and the moment that it should be ceased. Les Laboratoires Servier 2006-06 /pmc/articles/PMC3181767/ /pubmed/16889105 Text en Copyright: © 2006 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacological Aspects
Duval, Fabrice
Lebowitz, Barry D.
Macher, Jean-Paul
Treatments in depression
title Treatments in depression
title_full Treatments in depression
title_fullStr Treatments in depression
title_full_unstemmed Treatments in depression
title_short Treatments in depression
title_sort treatments in depression
topic Pharmacological Aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181767/
https://www.ncbi.nlm.nih.gov/pubmed/16889105
work_keys_str_mv AT duvalfabrice treatmentsindepression
AT lebowitzbarryd treatmentsindepression
AT macherjeanpaul treatmentsindepression